Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-05 · accession 0001061983-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $29.97 | +26.0K | 76.4K | +52% | +$779.3K |
| DM | 2026-03-05 | 2026-03-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $61.87 | -26.0K | 61.4K | -30% | -$1.61M |
| DM | 2026-03-05 | 2026-03-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $0.00 | -26.0K | 24.4K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-05 | M | A | 15,000 | $23.26 | 65,440 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-05 | S | D | 11,000 | $61.88 | 50,440 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-05 | M | A | 11,000 | $39.13 | 76,440 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-05 | S | D | 15,000 | $61.87 | 61,440 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-03-05 | M | D | 15,000 | $0.00 | 69,000 | D | $23.26 · 2022-03-31 to 2031-03-31 | 15,000 Common Stock | (F1) Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. |
| 6 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-03-05 | M | D | 11,000 | $0.00 | 24,403 | D | $39.13 · 2023-04-06 to 2033-03-06 | 11,000 Common Stock |